Pediatrics Doctors in New Castle, IN Accepting Medicare

9 Pediatrics doctors found. Showing 1 - 9

Mrs. Angela Sue Fornkohl Blum, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1000 N 16th St, Suite G-10, New Castle, IN 47362 Phone: 765-521-0901    Fax: 765-521-9891

Donald Joseph Miller, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1000 N 16th St, New Castle, IN 47362 Phone: 765-599-3177

Dr. Kenton Shawn Hilbish, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 152 Wittenbraker Ave, New Castle, IN 47362 Phone: 765-599-3100    Fax: 765-518-5365

Dr. Joshua J Underhill, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 152 Wittenbraker Ave, New Castle, IN 47362 Phone: 765-599-3100    Fax: 765-518-5365

Mohammad Lutfi Lababidi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 152 Wittenbraker Ave, New Castle, IN 47362 Phone: 765-599-3100

Dr. Robert E Gould, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1000 N 16th St, Suite G-10, New Castle, IN 47362 Phone: 765-521-0901    Fax: 765-521-9891

Mr. Brian William Sykes, Pediatrics Medicare: Medicare Enrolled Practice Location: 1000 N 16th St, New Castle, IN 47362 Phone: 765-599-3177    Fax: 765-599-3176

Cheryl Klein, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1000 N 16th St, New Castle, IN 47362 Phone: 765-599-3177

Heather Bricker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1000 N 16th St, New Castle, IN 47362 Phone: 765-599-3177

News Archive

Study: Simultaneous knee replacement linked with higher risk of adverse cardiovascular outcomes within 30 days

Replacing both knees in one surgery, or simultaneous total knee replacement was associated with significantly fewer prosthetic joint infections as well as other revision knee operations within one year after surgery, compared with total knee replacements performed in two separate procedures.

Guidant receives FDA approval to re-enter heart failure market

Guidant Corporation has announced U.S. Food and Drug Administration (FDA) approval to re-launch its CONTAK RENEWAL 3 family of cardiac resynchronization therapy (CRT) defibrillators in the United States.

NIH funds first artificial pancreas trial for pregnant women with type 1 diabetes in the U.S.

The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.

Japanese study finds proton beam therapy safe and effective for Stage I inoperable NSCLC

Proton beam therapy is safe and effective and may be superior to other conventional treatments for Stage I inoperable non-small cell lung cancer (NSCLC) patients, according to a study in the October issue of the International Journal of Radiation Oncology•Biology•Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

Researchers develop novel targeted therapy for triple-negative breast cancer

Researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University, have developed a novel targeted therapy for triple-negative breast cancer (TNBC) that uses a specially-designed nano-carrier to deliver the Chinese medicine compound gambogic acid (GA).

Read more Medical News

› Verified 4 days ago